25 XP   0   0   10

Voyager Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Voyager Therapeutics Inc together

PenkeI guess you are interested in Voyager Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Voyager Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Voyager Therapeutics Inc

I send you an email if I find something interesting about Voyager Therapeutics Inc.

Quick analysis of Voyager Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Voyager Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.35
Expected worth in 1 year
$7.62
How sure are you?
29.7%

+ What do you gain per year?

Total Gains per Share
$3.27
Return On Investment
43.5%

For what price can you sell your share?

Current Price per Share
$7.50
Expected price per share
$7.0677 - $10.57
How sure are you?
50%

1. Valuation of Voyager Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$7.50

Intrinsic Value Per Share

$-0.82 - $-0.99

Total Value Per Share

$3.53 - $3.36

2. Growth of Voyager Therapeutics Inc (5 min.)




Is Voyager Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$236.3m$68.7m$138.4m66.8%

How much money is Voyager Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money$33m-$11.5m$44.6m134.9%
Net Profit Margin-218.5%-1,446.2%--

How much money comes from the company's main activities?

3. Financial Health of Voyager Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#220 / 1016

Most Revenue
#136 / 1016

Most Profit
#66 / 1016

Most Efficient
#649 / 1016

What can you expect buying and holding a share of Voyager Therapeutics Inc? (5 min.)

Welcome investor! Voyager Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Voyager Therapeutics Inc.

What can you expect buying and holding a share of Voyager Therapeutics Inc?

First you should know what it really means to hold a share of Voyager Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Voyager Therapeutics Inc is $7.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Voyager Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Voyager Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.35. Based on the TTM, the Book Value Change Per Share is $0.82 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Voyager Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.0413.8%0.618.1%-0.21-2.8%0.010.1%-0.18-2.4%
Usd Book Value Change Per Share1.1114.8%0.8210.9%-0.17-2.2%0.172.3%0.121.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.1114.8%0.8210.9%-0.17-2.2%0.172.3%0.121.6%
Usd Price Per Share8.44-8.84-6.39-9.61-10.39-
Price to Earnings Ratio2.03--2.05--2.00--2.61--5.10-
Price-to-Total Gains Ratio7.63--10.71--10.38--23.00--32.08-
Price to Book Ratio1.94-2.35-5.11-4.86-5.42-
Price-to-Total Gains Ratio7.63--10.71--10.38--23.00--32.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.5
Number of shares133
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.820.17
Usd Total Gains Per Share0.820.17
Gains per Quarter (133 shares)108.5723.25
Gains per Year (133 shares)434.2793.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1043442409383
208698580186176
30130312920279269
40173717260372362
50217121600465455
60260625940558548
70304030280651641
80347434620744734
90390838960837827
100434343300930920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%4.08.00.033.3%6.014.00.030.0%6.031.00.016.2%6.031.00.016.2%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%11.025.01.029.7%11.025.01.029.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.037.00.0%0.00.037.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%11.025.01.029.7%11.025.01.029.7%

Fundamentals of Voyager Therapeutics Inc

About Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 21:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Voyager Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Voyager Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 62.6% means that $0.63 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Voyager Therapeutics Inc:

  • The MRQ is 62.6%. The company is making a huge profit. +2
  • The TTM is -218.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ62.6%TTM-218.5%+281.1%
TTM-218.5%YOY-1,446.2%+1,227.7%
TTM-218.5%5Y-591.7%+373.2%
5Y-591.7%10Y-652.9%+61.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ62.6%-199.6%+262.2%
TTM-218.5%-213.0%-5.5%
YOY-1,446.2%-279.3%-1,166.9%
5Y-591.7%-438.4%-153.3%
10Y-652.9%-605.5%-47.4%
1.1.2. Return on Assets

Shows how efficient Voyager Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • 16.1% Return on Assets means that Voyager Therapeutics Inc generated $0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Voyager Therapeutics Inc:

  • The MRQ is 16.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.1%TTM9.3%+6.8%
TTM9.3%YOY-6.2%+15.4%
TTM9.3%5Y-0.9%+10.2%
5Y-0.9%10Y-8.1%+7.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.1%-13.5%+29.6%
TTM9.3%-12.9%+22.2%
YOY-6.2%-11.8%+5.6%
5Y-0.9%-14.1%+13.2%
10Y-8.1%-16.0%+7.9%
1.1.3. Return on Equity

Shows how efficient Voyager Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • 23.9% Return on Equity means Voyager Therapeutics Inc generated $0.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Voyager Therapeutics Inc:

  • The MRQ is 23.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 13.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ23.9%TTM13.8%+10.1%
TTM13.8%YOY-19.4%+33.1%
TTM13.8%5Y-6.6%+20.4%
5Y-6.6%10Y-55.3%+48.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.9%-16.9%+40.8%
TTM13.8%-16.1%+29.9%
YOY-19.4%-15.1%-4.3%
5Y-6.6%-19.9%+13.3%
10Y-55.3%-20.9%-34.4%

1.2. Operating Efficiency of Voyager Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Voyager Therapeutics Inc is operating .

  • Measures how much profit Voyager Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 60.0% means the company generated $0.60  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Voyager Therapeutics Inc:

  • The MRQ is 60.0%. The company is operating very efficient. +2
  • The TTM is -255.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ60.0%TTM-255.6%+315.6%
TTM-255.6%YOY-1,467.0%+1,211.3%
TTM-255.6%5Y-610.3%+354.6%
5Y-610.3%10Y-661.5%+51.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ60.0%-295.1%+355.1%
TTM-255.6%-225.8%-29.8%
YOY-1,467.0%-288.4%-1,178.6%
5Y-610.3%-477.4%-132.9%
10Y-661.5%-625.6%-35.9%
1.2.2. Operating Ratio

Measures how efficient Voyager Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.40 means that the operating costs are $0.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Voyager Therapeutics Inc:

  • The MRQ is 0.400. The company is very efficient in keeping operating costs low. +2
  • The TTM is 3.663. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.400TTM3.663-3.264
TTM3.663YOY15.860-12.197
TTM3.6635Y7.555-3.891
5Y7.55510Y10.993-3.439
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4003.090-2.690
TTM3.6633.264+0.399
YOY15.8603.783+12.077
5Y7.5555.679+1.876
10Y10.9937.894+3.099

1.3. Liquidity of Voyager Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Voyager Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.96 means the company has $4.96 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Voyager Therapeutics Inc:

  • The MRQ is 4.956. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.649. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.956TTM7.649-2.693
TTM7.649YOY1.737+5.912
TTM7.6495Y4.863+2.786
5Y4.86310Y6.200-1.338
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9563.914+1.042
TTM7.6494.220+3.429
YOY1.7375.388-3.651
5Y4.8636.045-1.182
10Y6.2006.406-0.206
1.3.2. Quick Ratio

Measures if Voyager Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 7.40 means the company can pay off $7.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Voyager Therapeutics Inc:

  • The MRQ is 7.401. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.133. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.401TTM9.133-1.732
TTM9.133YOY2.136+6.997
TTM9.1335Y6.317+2.816
5Y6.31710Y11.031-4.714
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4013.572+3.829
TTM9.1333.998+5.135
YOY2.1365.390-3.254
5Y6.3175.969+0.348
10Y11.0316.287+4.744

1.4. Solvency of Voyager Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Voyager Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Voyager Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33 means that Voyager Therapeutics Inc assets are financed with 32.7% credit (debt) and the remaining percentage (100% - 32.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Voyager Therapeutics Inc:

  • The MRQ is 0.327. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.363. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.327TTM0.363-0.036
TTM0.363YOY0.634-0.270
TTM0.3635Y0.555-0.191
5Y0.55510Y0.511+0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3270.336-0.009
TTM0.3630.334+0.029
YOY0.6340.269+0.365
5Y0.5550.366+0.189
10Y0.5110.390+0.121
1.4.2. Debt to Equity Ratio

Measures if Voyager Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 48.6% means that company has $0.49 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Voyager Therapeutics Inc:

  • The MRQ is 0.486. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.573. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.486TTM0.573-0.087
TTM0.573YOY1.770-1.196
TTM0.5735Y1.540-0.967
5Y1.54010Y1.667-0.127
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4860.382+0.104
TTM0.5730.396+0.177
YOY1.7700.335+1.435
5Y1.5400.434+1.106
10Y1.6670.465+1.202

2. Market Valuation of Voyager Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Voyager Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Voyager Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of 2.03 means the investor is paying $2.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Voyager Therapeutics Inc:

  • The EOD is 1.805. Based on the earnings, the company is cheap. +2
  • The MRQ is 2.032. Based on the earnings, the company is cheap. +2
  • The TTM is -2.046. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.805MRQ2.032-0.226
MRQ2.032TTM-2.046+4.078
TTM-2.046YOY-2.000-0.046
TTM-2.0465Y-2.615+0.568
5Y-2.61510Y-5.101+2.486
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.805-2.259+4.064
MRQ2.032-2.569+4.601
TTM-2.046-2.664+0.618
YOY-2.000-4.120+2.120
5Y-2.615-6.258+3.643
10Y-5.101-6.171+1.070
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Voyager Therapeutics Inc:

  • The EOD is -3.825. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.305. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -21.070. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.825MRQ-4.305+0.479
MRQ-4.305TTM-21.070+16.766
TTM-21.070YOY-3.055-18.015
TTM-21.0705Y-7.329-13.741
5Y-7.32910Y-8.224+0.895
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.825-2.924-0.901
MRQ-4.305-3.246-1.059
TTM-21.070-3.488-17.582
YOY-3.055-5.620+2.565
5Y-7.329-8.315+0.986
10Y-8.224-8.826+0.602
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Voyager Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.94 means the investor is paying $1.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Voyager Therapeutics Inc:

  • The EOD is 1.723. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.939. Based on the equity, the company is underpriced. +1
  • The TTM is 2.345. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.723MRQ1.939-0.216
MRQ1.939TTM2.345-0.406
TTM2.345YOY5.108-2.763
TTM2.3455Y4.855-2.510
5Y4.85510Y5.423-0.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7231.851-0.128
MRQ1.9392.090-0.151
TTM2.3452.095+0.250
YOY5.1082.844+2.264
5Y4.8553.466+1.389
10Y5.4233.815+1.608
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Voyager Therapeutics Inc.

3.1. Institutions holding Voyager Therapeutics Inc

Institutions are holding 48.998% of the shares of Voyager Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Armistice Capital, LLC7.8010.48814236000580001.3882
2023-12-31EcoR1 Capital, LLC7.09290.844385150700
2023-12-31BlackRock Inc4.84830.000626326791672916.7856
2023-12-31Vanguard Group Inc4.65860.00052529668477111.9223
2023-12-31Farallon Capital Management, L.L.C.2.37930.0541129200000
2023-12-31T. Rowe Price Associates, Inc.1.85040.00111004786-169301-14.4198
2023-12-31Dimensional Fund Advisors, Inc.1.71680.002393223115329119.6794
2023-12-31Geode Capital Management, LLC1.25020.0006678878319334.936
2023-12-31AQR Capital Management LLC1.17730.0102639287440465221.5374
2023-09-30D. E. Shaw & Co LP1.15310.0051626123-321850-33.9514
2023-12-31State Street Corporation1.14140.0003619812375836.455
2023-12-31Federated Hermes Inc1.01580.0116551576-32309-5.5335
2023-12-31American Century Companies Inc0.8660.002747022915732450.2785
2023-12-31Acadian Asset Management LLC0.76950.0137417821-212342-33.6964
2023-12-31Goldman Sachs Group Inc0.66310.0003360050218931155.1393
2023-12-31GlobeFlex Capital, L.P.0.61010.2854331290-122305-26.9635
2023-12-31JPMorgan Chase & Co0.59580.000332352885372.7102
2023-12-31Northern Trust Corp0.580.0005314966121954.0278
2023-12-31Ikarian Capital, LLC0.56330.241730585700
2023-12-31Fiduciary Trust Co0.47770.036625939700
Total 41.21061.999722377685+475154+2.1%

3.2. Funds holding Voyager Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.99330.0009162539000
2024-03-28SPDR® S&P Biotech ETF1.82920.1225993259125201.2766
2024-03-28iShares Russell 2000 ETF1.75030.01359504354590.0483
2023-12-31T. Rowe Price Health Sciences1.26530.0394687052-14278-2.0358
2024-03-29Avantis US Small Cap Value ETF1.18580.055364391300
2023-12-31Vanguard Explorer Inv0.84170.01845706300
2024-02-29BlackRock Health Sciences Opps Inv A0.82110.043844588500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.80610.003643772548581.1223
2024-02-29BlackRock Health Sciences Term Trust0.6440.149234970500
2024-03-28iShares Russell 2000 Growth ETF0.61980.0269336562-391-0.116
2024-01-31Fidelity Small Cap Index0.59130.009432107346001.4535
2024-03-28iShares Biotechnology ETF0.58650.03893185004821617.839
2024-02-29JPM Thematics Genetic Thrps C2 Acc USD0.53230.3154289062-4374-1.4906
2023-12-31Federated Hermes MDT SCC Institutional0.49790.192827035300
2023-12-31Federated Hermes MDT Small Cap Core IS0.49790.193327035300
2023-12-31Federated Hermes MDT SCG Institutional0.48610.4767263955-32154-10.8588
2023-12-31Federated Hermes MDT Small Cap Growth IS0.48610.4784263955-32154-10.8588
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.35230.003819130033001.7553
2023-12-31ERSTE STOCK BIOTEC EUR R01 A0.34790.6054188899-13-0.0069
2024-02-29Fidelity Extended Market Index0.3170.0037172108-834-0.4822
Total 17.45192.79099476547-10245-0.1%

3.3. Insider Transactions

Insiders are holding 17.289% of the shares of Voyager Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-17Robin SwartzSELL25437.15
2024-01-17Todd Alfred CarterSELL12667.18
2023-10-03Peter P PfreundschuhSELL135676.99
2023-09-15Todd Alfred CarterSELL105008.16
2023-07-06Todd Alfred CarterSELL550010.8

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Voyager Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1070.816+36%-0.166+115%0.175+533%0.118+841%
Book Value Per Share--4.3523.815+14%1.265+244%2.244+94%2.070+110%
Current Ratio--4.9567.649-35%1.737+185%4.863+2%6.200-20%
Debt To Asset Ratio--0.3270.363-10%0.634-48%0.555-41%0.511-36%
Debt To Equity Ratio--0.4860.573-15%1.770-73%1.540-68%1.667-71%
Dividend Per Share----0%-0%-0%-0%
Eps--1.0390.609+70%-0.214+121%0.007+14233%-0.176+117%
Free Cash Flow Per Share---0.4900.334-247%-0.069-86%-0.060-88%-0.082-83%
Free Cash Flow To Equity Per Share---0.4430.499-189%-0.064-86%0.052-950%0.103-529%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.992--------
Intrinsic Value_10Y_min---0.818--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max---0.079--------
Intrinsic Value_3Y_min---0.074--------
Intrinsic Value_5Y_max---0.247--------
Intrinsic Value_5Y_min---0.223--------
Market Cap407254500.000-13%458297064.000479881552.500-4%346845082.500+32%521801615.700-12%564432723.243-19%
Net Profit Margin--0.626-2.185+449%-14.462+2410%-5.917+1045%-6.529+1143%
Operating Margin--0.600-2.556+526%-14.670+2544%-6.103+1117%-6.615+1202%
Operating Ratio--0.4003.663-89%15.860-97%7.555-95%10.993-96%
Pb Ratio1.723-13%1.9392.345-17%5.108-62%4.855-60%5.423-64%
Pe Ratio1.805-13%2.032-2.046+201%-2.000+198%-2.615+229%-5.101+351%
Price Per Share7.500-13%8.4408.838-4%6.388+32%9.610-12%10.395-19%
Price To Free Cash Flow Ratio-3.825+11%-4.305-21.070+389%-3.055-29%-7.329+70%-8.224+91%
Price To Total Gains Ratio6.776-13%7.626-10.711+240%-10.377+236%-23.004+402%-32.077+521%
Quick Ratio--7.4019.133-19%2.136+246%6.317+17%11.031-33%
Return On Assets--0.1610.093+73%-0.062+138%-0.009+106%-0.081+151%
Return On Equity--0.2390.138+73%-0.194+181%-0.066+128%-0.553+332%
Total Gains Per Share--1.1070.816+36%-0.166+115%0.175+533%0.118+841%
Usd Book Value--236320000.000207131750.000+14%68706500.000+244%121826850.000+94%112384702.703+110%
Usd Book Value Change Per Share--1.1070.816+36%-0.166+115%0.175+533%0.118+841%
Usd Book Value Per Share--4.3523.815+14%1.265+244%2.244+94%2.070+110%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--1.0390.609+70%-0.214+121%0.007+14233%-0.176+117%
Usd Free Cash Flow---26617000.00018140250.000-247%-3750000.000-86%-3271900.000-88%-4432648.649-83%
Usd Free Cash Flow Per Share---0.4900.334-247%-0.069-86%-0.060-88%-0.082-83%
Usd Free Cash Flow To Equity Per Share---0.4430.499-189%-0.064-86%0.052-950%0.103-529%
Usd Market Cap407254500.000-13%458297064.000479881552.500-4%346845082.500+32%521801615.700-12%564432723.243-19%
Usd Price Per Share7.500-13%8.4408.838-4%6.388+32%9.610-12%10.395-19%
Usd Profit--56395000.00033082500.000+70%-11539500.000+120%405850.000+13796%-6090891.892+111%
Usd Revenue--90061000.00062502000.000+44%342250.000+26214%28215450.000+219%16584216.216+443%
Usd Total Gains Per Share--1.1070.816+36%-0.166+115%0.175+533%0.118+841%
 EOD+3 -5MRQTTM+21 -12YOY+26 -75Y+23 -1010Y+21 -12

4.2. Fundamental Score

Let's check the fundamental score of Voyager Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.805
Price to Book Ratio (EOD)Between0-11.723
Net Profit Margin (MRQ)Greater than00.626
Operating Margin (MRQ)Greater than00.600
Quick Ratio (MRQ)Greater than17.401
Current Ratio (MRQ)Greater than14.956
Debt to Asset Ratio (MRQ)Less than10.327
Debt to Equity Ratio (MRQ)Less than10.486
Return on Equity (MRQ)Greater than0.150.239
Return on Assets (MRQ)Greater than0.050.161
Total9/10 (90.0%)

4.3. Technical Score

Let's check the technical score of Voyager Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.201
Ma 20Greater thanMa 508.931
Ma 50Greater thanMa 1008.758
Ma 100Greater thanMa 2008.343
OpenGreater thanClose7.500
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  1,51501,515781,59301,593-1,5930



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets351,281
Total Liabilities114,961
Total Stockholder Equity236,320
 As reported
Total Liabilities 114,961
Total Stockholder Equity+ 236,320
Total Assets = 351,281

Assets

Total Assets351,281
Total Current Assets319,684
Long-term Assets31,597
Total Current Assets
Cash And Cash Equivalents 68,802
Short-term Investments 162,073
Net Receivables 84,455
Other Current Assets 4,354
Total Current Assets  (as reported)319,684
Total Current Assets  (calculated)319,684
+/-0
Long-term Assets
Property Plant Equipment 30,004
Other Assets 0
Long-term Assets  (as reported)31,597
Long-term Assets  (calculated)30,004
+/- 1,593

Liabilities & Shareholders' Equity

Total Current Liabilities64,508
Long-term Liabilities50,453
Total Stockholder Equity236,320
Total Current Liabilities
Short-term Debt 3,200
Accounts payable 1,604
Other Current Liabilities 16,823
Total Current Liabilities  (as reported)64,508
Total Current Liabilities  (calculated)21,627
+/- 42,881
Long-term Liabilities
Capital Lease Obligations 20,293
Long-term Liabilities Other 1,001
Long-term Liabilities  (as reported)50,453
Long-term Liabilities  (calculated)21,294
+/- 29,159
Total Stockholder Equity
Common Stock44
Retained Earnings -261,182
Accumulated Other Comprehensive Income -48
Other Stockholders Equity 497,506
Total Stockholder Equity (as reported)236,320
Total Stockholder Equity (calculated)236,320
+/-0
Other
Capital Stock44
Cash and Short Term Investments 230,875
Common Stock Shares Outstanding 45,079
Current Deferred Revenue42,881
Liabilities and Stockholders Equity 351,281
Net Debt -48,509
Net Invested Capital 236,320
Net Working Capital 255,176
Property Plant and Equipment Gross 45,042
Short Long Term Debt Total 20,293



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302013-12-31
> Total Assets 
149
0
0
11,497
0
173,764
166,435
229,457
219,980
209,815
201,984
189,566
175,090
158,414
140,915
184,477
235,026
214,663
197,064
177,029
411,349
388,592
376,220
354,760
322,610
297,455
269,757
261,584
237,717
208,727
184,774
193,855
224,182
188,605
182,480
159,356
336,294
315,536
294,653
351,281
351,281294,653315,536336,294159,356182,480188,605224,182193,855184,774208,727237,717261,584269,757297,455322,610354,760376,220388,592411,349177,029197,064214,663235,026184,477140,915158,414175,090189,566201,984209,815219,980229,457166,435173,764011,49700149
   > Total Current Assets 
0
0
0
8,358
0
109,191
108,613
195,894
205,698
205,477
193,021
178,786
161,080
144,726
128,191
171,790
220,631
200,245
182,466
162,481
365,167
340,775
327,597
304,659
272,476
246,657
216,313
197,769
175,837
148,649
126,204
136,698
170,651
151,628
146,942
124,499
302,625
282,176
261,925
319,684
319,684261,925282,176302,625124,499146,942151,628170,651136,698126,204148,649175,837197,769216,313246,657272,476304,659327,597340,775365,167162,481182,466200,245220,631171,790128,191144,726161,080178,786193,021205,477205,698195,894108,613109,19108,358000
       Cash And Cash Equivalents 
135
0
0
7,035
0
84,748
66,533
31,309
33,895
67,032
63,507
36,641
43,604
66,300
48,201
31,530
140,371
59,614
42,142
46,859
113,261
79,885
82,640
86,042
165,227
144,321
147,447
104,440
117,799
117,844
111,475
117,433
131,873
78,329
96,860
98,959
268,321
244,293
65,269
68,802
68,80265,269244,293268,32198,95996,86078,329131,873117,433111,475117,844117,799104,440147,447144,321165,22786,04282,64079,885113,26146,85942,14259,614140,37131,53048,20166,30043,60436,64163,50767,03233,89531,30966,53384,74807,03500135
       Short-term Investments 
0
0
0
163,028
0
23,870
41,138
163,028
170,097
136,961
127,646
137,777
114,066
75,023
77,386
137,522
77,827
136,509
137,459
108,947
245,238
247,577
224,760
195,491
85,704
85,349
52,571
76,698
43,707
25,137
10,024
15,106
34,960
69,727
34,778
19,889
4,993
28,453
187,667
162,073
162,073187,66728,4534,99319,88934,77869,72734,96015,10610,02425,13743,70776,69852,57185,34985,704195,491224,760247,577245,238108,947137,459136,50977,827137,52277,38675,023114,066137,777127,646136,961170,097163,02841,13823,8700163,028000
       Net Receivables 
0
0
0
0
0
0
0
411
411
0
0
2,303
2,303
0
0
122
122
0
0
201
0
10,063
14,033
18,972
16,283
12,686
12,689
8,107
4,253
1,758
1,165
748
206
151
10,225
639
25,328
3,350
3,253
84,455
84,4553,2533,35025,32863910,2251512067481,1651,7584,2538,10712,68912,68616,28318,97214,03310,063020100122122002,3032,303004114110000000
       Other Current Assets 
0
0
0
423
0
213
263
382
1,706
1,484
1,868
541
3,410
3,403
2,604
766
2,433
4,122
2,865
1,360
6,668
3,250
6,164
1,952
5,262
4,301
3,606
1,575
10,078
3,910
3,540
1,701
3,612
3,421
5,079
4,233
3,983
6,080
5,736
4,354
4,3545,7366,0803,9834,2335,0793,4213,6121,7013,5403,91010,0781,5753,6064,3015,2621,9526,1643,2506,6681,3602,8654,1222,4337662,6043,4033,4105411,8681,4841,7063822632130423000
   > Long-term Assets 
0
0
0
3,139
0
64,573
57,822
33,563
14,282
4,338
8,963
10,780
14,010
13,688
12,724
12,687
14,395
14,418
14,598
14,548
46,182
47,817
48,623
50,101
50,134
50,798
53,444
63,815
61,880
60,078
58,570
57,157
53,531
36,977
35,538
34,857
33,669
33,360
32,728
31,597
31,59732,72833,36033,66934,85735,53836,97753,53157,15758,57060,07861,88063,81553,44450,79850,13450,10148,62347,81746,18214,54814,59814,41814,39512,68712,72413,68814,01010,7808,9634,33814,28233,56357,82264,57303,139000
       Property Plant Equipment 
0
0
0
2,804
0
3,240
3,277
3,234
3,558
3,603
4,253
7,893
10,134
10,674
10,558
10,283
11,458
12,244
12,527
12,771
43,440
44,534
44,623
46,458
46,324
47,193
49,343
61,499
59,633
57,831
56,791
55,378
51,752
35,462
34,023
33,342
32,154
31,767
31,135
30,004
30,00431,13531,76732,15433,34234,02335,46251,75255,37856,79157,83159,63361,49949,34347,19346,32446,45844,62344,53443,44012,77112,52712,24411,45810,28310,55810,67410,1347,8934,2533,6033,5583,2343,2773,24002,804000
       Long Term Investments 
0
0
0
30,008
0
0
0
30,008
9,989
0
2,416
1,360
2,000
1,480
960
1,100
1,320
860
800
628
1,280
1,280
2,024
1,920
1,432
1,422
2,184
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002,1841,4221,4321,9202,0241,2801,2806288008601,3201,1009601,4802,0001,3602,41609,98930,00800030,008000
       Long-term Assets Other 
0
0
0
335
0
1,304
1,623
321
735
735
2,294
1,527
1,876
1,534
1,206
1,304
1,617
1,314
1,271
1,149
1,462
2,003
1,976
1,723
2,378
2,183
1,917
2,316
2,247
2,247
1,779
1,779
1,779
1,515
1,515
1,515
1,515
1,593
1,593
0
01,5931,5931,5151,5151,5151,5151,7791,7791,7792,2472,2472,3161,9172,1832,3781,7231,9762,0031,4621,1491,2711,3141,6171,3041,2061,5341,8761,5272,2947357353211,6231,3040335000
> Total Liabilities 
3,982
0
0
10,348
0
69,049
64,716
60,383
56,383
54,111
52,860
53,644
52,393
53,123
55,709
50,426
136,733
132,691
131,476
130,583
310,655
270,188
268,064
255,248
242,853
220,571
103,521
107,264
101,509
98,191
97,352
98,800
148,251
128,553
102,657
100,336
119,333
116,510
118,433
114,961
114,961118,433116,510119,333100,336102,657128,553148,25198,80097,35298,191101,509107,264103,521220,571242,853255,248268,064270,188310,655130,583131,476132,691136,73350,42655,70953,12352,39353,64452,86054,11156,38360,38364,71669,049010,348003,982
   > Total Current Liabilities 
3,982
0
0
2,474
0
22,790
23,366
23,931
23,077
19,760
19,387
13,802
11,064
11,836
20,941
15,897
30,940
29,095
30,027
31,673
58,776
69,146
80,172
76,012
72,537
67,531
42,052
26,766
24,751
24,688
26,701
50,981
101,677
97,932
73,242
72,591
19,939
45,398
61,688
64,508
64,50861,68845,39819,93972,59173,24297,932101,67750,98126,70124,68824,75126,76642,05267,53172,53776,01280,17269,14658,77631,67330,02729,09530,94015,89720,94111,83611,06413,80219,38719,76023,07723,93123,36622,79002,474003,982
       Short-term Debt 
0
0
0
6,305
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,276
2,843
3,016
3,193
3,306
3,421
3,539
4,198
4,596
4,870
5,248
5,571
5,748
2,526
2,746
2,832
2,922
3,013
3,106
3,200
3,2003,1063,0132,9222,8322,7462,5265,7485,5715,2484,8704,5964,1983,5393,4213,3063,1933,0162,8439,27600000000000000006,305000
       Short Long Term Debt 
0
0
0
6,305
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000006,305000
       Accounts payable 
950
0
0
1,554
0
1,459
541
612
1,697
454
787
550
557
307
911
1,020
1,372
1,558
1,422
1,038
2,261
2,230
4,026
4,070
4,815
2,045
3,386
634
3,177
790
592
574
1,200
1,218
1,337
2,566
3,698
1,659
3,270
1,604
1,6043,2701,6593,6982,5661,3371,2181,2005745927903,1776343,3862,0454,8154,0704,0262,2302,2611,0381,4221,5581,3721,0209113075575507874541,6976125411,45901,55400950
       Other Current Liabilities 
105
0
0
920
0
1,742
3,236
3,730
2,661
5,049
6,304
6,488
5,593
7,314
10,493
11,497
9,351
7,697
8,355
9,788
2,673
11,782
16,588
21,516
17,493
18,154
21,665
14,205
10,535
10,959
11,324
2,740
7,735
7,185
12,529
1,366
-71,233
9,060
11,051
16,823
16,82311,0519,060-71,2331,36612,5297,1857,7352,74011,32410,95910,53514,20521,66518,15417,49321,51616,58811,7822,6739,7888,3557,6979,35111,49710,4937,3145,5936,4886,3045,0492,6613,7303,2361,742092000105
   > Long-term Liabilities 
0
0
0
7,874
0
46,259
41,350
36,452
33,306
34,351
33,473
39,842
41,329
41,287
34,768
34,529
105,793
103,596
101,449
98,910
251,879
201,042
187,892
179,236
170,316
153,040
61,469
80,498
76,758
73,503
70,651
47,819
46,574
30,621
29,415
27,745
99,394
71,112
56,745
50,453
50,45356,74571,11299,39427,74529,41530,62146,57447,81970,65173,50376,75880,49861,469153,040170,316179,236187,892201,042251,87998,910101,449103,596105,79334,52934,76841,28741,32939,84233,47334,35133,30636,45241,35046,25907,874000
       Other Liabilities 
0
0
0
7,874
0
46,259
41,350
36,452
33,306
34,351
33,473
39,842
41,329
41,287
34,768
34,529
105,793
103,596
101,449
98,910
251,879
168,437
156,094
148,261
140,228
123,857
33,210
37,089
34,615
32,657
30,640
9,211
9,450
8,880
29,415
7,451
0
52,383
0
0
0052,38307,45129,4158,8809,4509,21130,64032,65734,61537,08933,210123,857140,228148,261156,094168,437251,87998,910101,449103,596105,79334,52934,76841,28741,32939,84233,47334,35133,30636,45241,35046,25907,874000
       Deferred Long Term Liability 
0
0
0
1,314
0
0
0
0
33,266
34,317
33,444
39,817
40,306
40,268
33,753
33,517
5,279
5,282
5,642
5,710
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005,7105,6425,2825,27933,51733,75340,26840,30639,81733,44434,31733,26600001,314000
> Total Stockholder Equity
0
0
0
1,149
0
104,715
101,719
169,074
163,597
155,704
149,124
135,922
122,697
105,291
85,206
134,051
98,293
81,972
65,588
46,446
100,694
118,404
108,156
99,512
79,757
76,884
166,236
154,320
136,208
110,536
87,422
95,055
75,931
60,052
79,823
59,020
216,961
199,026
176,220
236,320
236,320176,220199,026216,96159,02079,82360,05275,93195,05587,422110,536136,208154,320166,23676,88479,75799,512108,156118,404100,69446,44665,58881,97298,293134,05185,206105,291122,697135,922149,124155,704163,597169,074101,719104,71501,149000
   Common Stock
0
0
0
1
0
19
1
25
25
25
25
26
26
26
26
32
32
32
32
32
37
37
37
37
37
37
37
37
38
38
38
38
38
38
38
38
43
44
44
44
44444443383838383838383837373737373737373232323232262626262525252511901000
   Retained Earnings Total Equity00-291,676-269,468-393,512-369,886-387,510-368,423-347,104-352,813-327,676-297,556-275,907-259,981-345,592-336,911-312,648-300,074-285,068-296,221-269,051-246,520-226,231-200,689-160,713-148,884-125,538-106,663-90,015-75,342-66,345-57,01000000000
   Accumulated Other Comprehensive Income 
0
0
0
-21,979
0
-20
38
-251
30
60
630
-52
325
30
-455
-287
-162
-125
-174
-133
-75
101
-15
-104
421
145
-60
-134
-123
-126
-128
-138
-223
-364
-337
-219
-132
-133
-248
-48
-48-248-133-132-219-337-364-223-138-128-126-123-134-60145421-104-15101-75-133-174-125-162-287-45530325-526306030-25138-200-21,979000
   Capital Surplus 
0
0
0
0
0
0
0
0
220,552
221,964
223,811
225,963
229,009
230,773
234,519
295,019
299,112
308,296
312,250
315,598
396,953
403,334
408,208
412,227
416,210
422,294
426,240
430,324
433,849
438,300
440,325
442,259
444,539
447,888
450,008
452,713
486,518
490,791
0
0
00490,791486,518452,713450,008447,888444,539442,259440,325438,300433,849430,324426,240422,294416,210412,227408,208403,334396,953315,598312,250308,296299,112295,019234,519230,773229,009225,963223,811221,964220,55200000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
21,979
0
143,338
148,858
219,122
220,552
221,964
223,811
225,963
229,009
230,773
234,519
295,019
299,112
308,296
312,250
315,598
396,953
403,334
408,208
412,227
416,210
422,294
426,240
430,324
433,849
438,300
440,325
442,259
444,539
447,888
450,008
452,713
486,518
490,791
494,001
497,506
497,506494,001490,791486,518452,713450,008447,888444,539442,259440,325438,300433,849430,324426,240422,294416,210412,227408,208403,334396,953315,598312,250308,296299,112295,019234,519230,773229,009225,963223,811221,964220,552219,122148,858143,338021,979000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue250,008
Cost of Revenue-4,441
Gross Profit245,567245,567
 
Operating Income (+$)
Gross Profit245,567
Operating Expense-123,553
Operating Income122,014122,014
 
Operating Expense (+$)
Research Development87,731
Selling General Administrative35,822
Selling And Marketing Expenses0
Operating Expense123,553123,553
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-11,721
Net Interest Income11,721
 
Pretax Income (+$)
Operating Income122,014
Net Interest Income11,721
Other Non-Operating Income Expenses0
Income Before Tax (EBT)133,738110,290
EBIT - interestExpense = 122,014
133,738
132,330
Interest Expense0
Earnings Before Interest and Taxes (EBIT)122,014133,738
Earnings Before Interest and Taxes (EBITDA)126,455
 
After tax Income (+$)
Income Before Tax133,738
Tax Provision-1,408
Net Income From Continuing Ops132,330132,330
Net Income132,330
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses127,994
Total Other Income/Expenses Net11,724-11,721
 

Technical Analysis of Voyager Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Voyager Therapeutics Inc. The general trend of Voyager Therapeutics Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Voyager Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Voyager Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.84 < 8.91 < 10.57.

The bearish price targets are: 7.08 > 7.08 > 7.0677.

Tweet this
Voyager Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Voyager Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Voyager Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Voyager Therapeutics Inc. The current macd is -0.36643972.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Voyager Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Voyager Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Voyager Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Voyager Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartVoyager Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Voyager Therapeutics Inc. The current adx is 24.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Voyager Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Voyager Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Voyager Therapeutics Inc. The current sar is 9.34049223.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Voyager Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Voyager Therapeutics Inc. The current rsi is 34.20. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Voyager Therapeutics Inc Daily Relative Strength Index (RSI) ChartVoyager Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Voyager Therapeutics Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Voyager Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Voyager Therapeutics Inc Daily Stochastic Oscillator ChartVoyager Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Voyager Therapeutics Inc. The current cci is -159.96134631.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Voyager Therapeutics Inc Daily Commodity Channel Index (CCI) ChartVoyager Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Voyager Therapeutics Inc. The current cmo is -48.88798279.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Voyager Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartVoyager Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Voyager Therapeutics Inc. The current willr is -92.83425287.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Voyager Therapeutics Inc Daily Williams %R ChartVoyager Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Voyager Therapeutics Inc.

Voyager Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Voyager Therapeutics Inc. The current atr is 0.49384362.

Voyager Therapeutics Inc Daily Average True Range (ATR) ChartVoyager Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Voyager Therapeutics Inc. The current obv is 14,361,851.

Voyager Therapeutics Inc Daily On-Balance Volume (OBV) ChartVoyager Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Voyager Therapeutics Inc. The current mfi is 5.46140777.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Voyager Therapeutics Inc Daily Money Flow Index (MFI) ChartVoyager Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Voyager Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Voyager Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Voyager Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.201
Ma 20Greater thanMa 508.931
Ma 50Greater thanMa 1008.758
Ma 100Greater thanMa 2008.343
OpenGreater thanClose7.500
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Voyager Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Voyager Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Voyager Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Voyager Therapeutics Inc

I send you an email if I find something interesting about Voyager Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Voyager Therapeutics Inc.

Receive notifications about Voyager Therapeutics Inc in your mailbox!